← Back to catalogue
Published

eosinopenia

vr.tr.eosinopenia · thing-q490539

Enable an agent to recognise eosinopenia, assess the reliability and context of a low circulating eosinophil count, and identify appropriate review or monitoring needs.

Thing Registry Information and virtual systems INF.KNW

Bundle → Layer → Finding → Questions Filled

5 bundles · 9 layers · 15 findings · 23 questions

Eosinopenia definition Determines which blood-count observations qualify as this registered state.

Low-count boundary

Records the criterion under which a circulating eosinophil count is called low.

Criterion-bound classification

Eosinopenia denotes a low blood eosinophil count; the model must retain the criterion used for each classification. [Merck Manual](https://www.merckmanuals.com/home/blood-disorders/white-blood-cell-disorders/eosinophilic-disorders)

  1. Which threshold, units and comparison operator define eosinopenia for this observation? definition
  2. Which laboratory reference interval or published operational definition supports that threshold for this population? provenance

Absolute and relative distinction

Separates the eosinophil concentration from its share of the leukocyte differential.

Percentage denominator check

When deriving an absolute count, multiply the same-specimen total leukocyte count by the eosinophil percentage divided by 100; retain the inputs and their reporting precision.

  1. Is the low result an absolute count, a percentage, or both? measurement
  2. Does the absolute count meet the selected criterion, or is only the percentage reduced? boundary
Low-count measurement Establishes whether the laboratory result supports a reliable low-count observation.

Specimen and method

Connects the eosinophil result to its specimen and differential-count procedure.

Traceable eosinophil result

Retain collection time, specimen identity, laboratory, differential method and relevant quality flags so the observation can be checked and compared.

  1. When was the specimen collected, and was the eosinophil differential automated, manual or otherwise measured? provenance
  2. Were specimen-quality issues, analyser flags or reporting corrections recorded for this result? measurement

Zero and precision

Interprets very low results without overstating what the assay established.

Reported-zero interpretation

Preserve whether zero is a rounded numerical report, a below-limit result or no eosinophils observed in a finite manual differential.

  1. What reporting increment, quantification limit or manual differential cell total applies to this result? measurement
  2. Does the available report support a quantified low count, a bounded result or only an unresolved reported zero? boundary
Eosinopenia course and exposures Places low counts within an individual timeline and evaluates exposure-related explanations.

Serial eosinophil course

Distinguishes the observed episode from isolated measurements and baseline variation.

Dated low-count episode

Describe onset, recurrence and resolution using dated measurements, retaining changes in laboratory method or low-count criterion.

  1. Which earlier and subsequent absolute counts establish the baseline and duration of the observed reduction? measurement
  2. Are collection times, laboratories and classification criteria sufficiently comparable to support the assigned course? boundary

Glucocorticoid and treatment context

Examines the relationship between eosinophil-lowering exposures and blood sampling.

Exposure-linked count reduction

Glucocorticoids can rapidly lower circulating eosinophils; mechanistic research supports CXCR4-dependent bone-marrow migration, so a falling blood count must not automatically be interpreted as cellular destruction. [Primary study](https://pubmed.ncbi.nlm.nih.gov/32659786/)

  1. Which glucocorticoids or eosinophil-targeting therapies preceded the sample, at what doses and intervals? provenance
  2. Do pretreatment and follow-up counts support an exposure-related explanation, and what competing explanations remain? boundary
Clinical meaning and review Constrains what an agent may infer from eosinopenia and identifies the evidence needed for further review.

Associated conditions

Records relevant illness and endocrine context without converting association into diagnosis.

Nonspecific clinical association

Low eosinophil counts can occur with sepsis, Cushing syndrome and corticosteroid treatment; the count alone does not identify which explanation applies. [Merck Manual](https://www.merckmanuals.com/home/blood-disorders/white-blood-cell-disorders/eosinophilic-disorders)

  1. Which concurrent illnesses or endocrine findings are independently documented at the time of sampling? provenance
  2. What evidence beyond eosinopenia supports each proposed cause or use as an illness marker? boundary

Review and resolution

Relates follow-up decisions to measurement confidence, persistence and the broader clinical presentation.

Context-led follow-up

Record whether the low count needs report clarification, repeat measurement or clinician review, with a stated reason; count normalisation alone does not establish resolution of a linked illness.

  1. What uncertainty, persistence or accompanying clinical finding justifies clarification, repeat testing or clinician review? action
  2. Which observations would establish resolution of the low-count state, and which separate evidence is needed to reassess its proposed cause? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these regional variation hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of eosinopenia this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Information and virtual systems
Entry kind
thing
Plane
INF
Domain
INF.KNW

What it is Filled

Eosinopenia is a reduction in circulating blood eosinophils below the applicable reference interval or specified threshold, usually described as a laboratory finding rather than a distinct disease.

In scope

  • Absolute circulating eosinophil counts assessed against an explicitly recorded reference interval or decision threshold
  • Distinction between absolute eosinopenia and a reduced eosinophil percentage
  • Measurement limitations affecting very low or reported-zero counts
  • Transient, recurrent and persistent low-count observations
  • Evidence linking the observation to medication exposure or concurrent illness
  • Limits on diagnostic inference and grounds for clinical review

Out of scope

  • Complete models of sepsis, endocrine disorders or other possible underlying conditions
  • Eosinophilia and hypereosinophilic syndromes
  • Eosinophil biology outside what is needed to interpret the low-count state
  • Diagnosis of tissue eosinophil depletion from blood measurements alone
  • General leukopenia, neutropenia and bone-marrow failure models
  • Prescribing or changing treatment for an underlying condition

Why it exists Filled

Enable an agent to recognise eosinopenia, assess the reliability and context of a low circulating eosinophil count, and identify appropriate review or monitoring needs.

Distinguishing features Filled

  • An instance requires a circulating eosinophil result that meets an identified low-count criterion; an unspecified 'abnormal differential' is insufficient.
  • A low eosinophil percentage must be checked against the absolute count because the proportion also depends on other leukocyte populations.
  • A decline from an individual's baseline is distinct from crossing a low-count threshold and should be recorded separately.
  • A reported zero requires interpretation through the assay's reporting precision and detection capability before being treated as absence of circulating eosinophils.
  • The blood-count state is distinct from its cause: corticosteroid exposure or an infection diagnosis does not itself establish measured eosinopenia.

What robots and AI may and may not do Filled

Must not

  • Interpret a person's blood result as a diagnosis.
  • Treat eosinopenia alone as proof of infection, stress or steroid use.
  • Advise stopping prescribed steroids based on a blood count.
  • Share a person's laboratory results without consent.

Only with a human decision

  • Any clinical decision based on a person's blood count.

May

  • Explain what a low eosinophil count means as a laboratory finding, citing reference sources.
  • Note that reference intervals vary by laboratory and population.

Moral aspects Filled

  • A lab value out of context can cause needless fear or false reassurance.
  • Laboratory results are personal health data.

Who is affected

  • Patients
  • Clinicians interpreting results

Owners Filled

Steward

Nobody owns the finding; the laboratory and treating clinician answer for each result.

Links to other meta-models Filled

parent

  • Q396013 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.eosinopenia
  • Wikidata: Q490539 (https://www.wikidata.org/wiki/Q490539)

Direct properties not applicable Not applicable

  • Absolute eosinophil count: cells/µL or ×10^9/L; 1 ×10^9/L = 1000 cells/µL
  • Eosinophil proportion: % of leukocytes
  • Concurrent total leukocyte count: cells/µL or ×10^9/L from the same specimen
  • Low-count criterion: Threshold, units, comparison operator, laboratory or study source, and applicable population
  • Measurement qualification: Quantified low; reported zero; below quantification limit; flagged; unresolved
  • Episode course: Single observation; transient; recurrent; persistent; resolved; indeterminate, with supporting dates
  • Medication timing: Links to relevant medication administrations, including agent, dose, route and interval before sampling
  • Clinical-context attribution: Linked condition or exposure; suspected, supported, contradicted or unresolved attribution

Plane INF: no invented physical properties.

Recognition not applicable Not applicable

Not applicable

Eosinopenia has no specific visible identifying features and is established through blood testing.

Capabilities and actions required Filled

  • Classify a result against a documented low-count criterion while preserving uncertainty.
  • Calculate or cross-check the absolute count using the concurrent leukocyte count and eosinophil percentage.
  • Identify low or zero results that require clarification of laboratory reporting limits.
  • Compare serial counts with medication administrations and clinical events.
  • Summarise supported explanations, competing explanations and missing evidence for clinical review.
  • Track resolution or persistence without treating count recovery as proof that an underlying illness has resolved.

Hazards and failure modes required Filled

  • Treating an isolated low eosinophil count as a diagnosis can cause unnecessary concern or inappropriate clinical decisions.
  • Confusing an eosinophil percentage with an absolute count can lead to incorrect interpretation.
  • Ignoring laboratory limitations or the broader clinical context can lead to misleading conclusions about the finding.

Standards and interfaces required Filled

  • The International Organization for Standardization issues ISO 15189, which sets quality and competence requirements for medical laboratories producing eosinophil count results.

Context of use required Filled

  • Eosinopenia is encountered when reviewing a blood count with a white blood cell differential.
  • It describes a laboratory finding interpreted alongside the laboratory reference interval, other results and the person's clinical context.

Sources Filled

  1. Wikidata item Q490539: eosinopenia - identity and sense of the item
  2. Wikipedia: Eosinopenia - general description of the item

Open questions

  • Which low-count definitions are supported for the intended age groups, laboratories and clinical settings, particularly where reference intervals include zero?
  • How should counts near zero be classified across automated analysers and manual differentials with different reporting limits?
  • What observation period and sampling comparability should be required before labelling eosinopenia persistent or recurrent?
  • In which patient populations does eosinopenia add validated diagnostic or prognostic information beyond other clinical observations, after accounting for corticosteroid exposure?
  • What evidence supports further evaluation of persistent isolated eosinopenia when other blood counts and the clinical assessment are unremarkable?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q490539/spec.json